Get the Stockscreener App
0.6672
4.30%
-0.03
After Hours:
.67
0.0028
+0.42%
Agilon Health Inc stock is traded at $0.6672, with a volume of 10.04M.
It is down -4.30% in the last 24 hours and down -37.06% over the past month.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.
See More
Previous Close:
$0.6972
Open:
$0.68
24h Volume:
10.04M
Relative Volume:
1.11
Market Cap:
$276.50M
Revenue:
$4.78B
Net Income/Loss:
$-284.68M
P/E Ratio:
-0.967
EPS:
-0.69
Net Cash Flow:
$-184.84M
1W Performance:
-16.23%
1M Performance:
-37.06%
6M Performance:
-80.32%
1Y Performance:
-76.09%
1-Day Range:
$0.6362
$0.6899
1-Week Range:
$0.6362
$0.855
52-Week Range:
$0.6362
$5.77
Agilon Health Inc Stock (AGL) Company Profile
Name
Agilon Health Inc
Sector
Industry
Phone
562-256-3800
Address
440 POLARIS PARKWAY, WESTERVILLE
Compare AGL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AGL
Agilon Health Inc
|
0.6672 | 289.05M | 4.78B | -284.68M | -184.84M | -0.69 |
|
HCA
Hca Healthcare Inc
|
476.61 | 107.56B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
205.26 | 17.95B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.00 | 14.09B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
229.23 | 14.41B | 16.08B | 1.20B | 1.06B | 17.82 |
|
EHC
Encompass Health Corp
|
115.27 | 11.58B | 5.51B | 494.70M | 386.40M | 4.84 |
Agilon Health Inc Stock (AGL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-20-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Aug-06-25 | Downgrade | Citigroup | Buy → Neutral |
| Apr-25-25 | Upgrade | Citigroup | Neutral → Buy |
| Apr-08-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jan-10-25 | Upgrade | Citigroup | Sell → Neutral |
| Jan-10-25 | Initiated | Needham | Hold |
| Dec-16-24 | Initiated | Macquarie | Neutral |
| Dec-11-24 | Initiated | Bernstein | Mkt Perform |
| Nov-11-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Nov-08-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-30-24 | Downgrade | Citigroup | Neutral → Sell |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Underperform |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| Apr-22-24 | Initiated | Citigroup | Neutral |
| Mar-06-24 | Initiated | Barclays | Underweight |
| Feb-26-24 | Downgrade | Jefferies | Buy → Hold |
| Feb-26-24 | Downgrade | TD Cowen | Outperform → Market Perform |
| Jan-08-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jan-08-24 | Downgrade | Stifel | Buy → Hold |
| Jan-08-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-05-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-05-24 | Downgrade | Truist | Buy → Hold |
| Dec-11-23 | Downgrade | Goldman | Buy → Neutral |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Nov-21-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-20-23 | Initiated | The Benchmark Company | Buy |
| Jun-13-23 | Initiated | Evercore ISI | In-line |
| Dec-09-22 | Initiated | Stifel | Buy |
| Sep-14-22 | Initiated | RBC Capital Mkts | Outperform |
| Sep-12-22 | Initiated | Goldman | Buy |
| Sep-07-22 | Resumed | Truist | Buy |
| Jun-24-22 | Initiated | BTIG Research | Neutral |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Oct-20-21 | Initiated | Jefferies | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| May-11-21 | Initiated | William Blair | Outperform |
| May-10-21 | Initiated | BofA Securities | Buy |
| May-10-21 | Initiated | Deutsche Bank | Buy |
| May-10-21 | Initiated | Goldman | Buy |
| May-10-21 | Initiated | JP Morgan | Overweight |
| May-10-21 | Initiated | Truist | Buy |
| May-10-21 | Initiated | Wells Fargo | Overweight |
| May-10-21 | Initiated | Wolfe Research | Outperform |
View All
Agilon Health Inc Stock (AGL) Latest News
Why agilon health (AGL) Shares Are Getting Obliterated Today - TradingView
agilon health stock falls after NYSE issues continued listing notice - Investing.com
What’s next for agilon health inc. stock priceQuarterly Trade Review & Daily Risk Controlled Trade Plans - newser.com
agilon receives notice of non-compliance with NYSE continued listing standards - MSN
Agilon announces receipt of notice of non-compliance with the NYSE continued listing standards - MarketScreener
agilon health plans reverse stock split to meet NYSE listing requirements - Investing.com India
AGILON health receives NYSE non-compliance notice for low stock price - StreetInsider
agilon Announces Receipt of Notice of Non-Compliance with the NYSE Continued Listing Standards - Business Wire
Analysts Have Been Trimming Their agilon health, inc. (NYSE:AGL) Price Target After Its Latest Report - simplywall.st
Rosen Law Firm Encourages agilon health, inc. Investors to Inquire About Securities Class Action InvestigationAGL - PR Newswire
Agilon Health, Inc. (NYSE:AGL) Q3 2025 Earnings Call Transcript - Insider Monkey
What earnings revisions data tells us about agilon health inc.Earnings Performance Report & AI Powered Market Entry Strategies - newser.com
Shamis & Gentile, P.A. Announces Investigation of Breaches - GlobeNewswire
Shamis & Gentile, P.A. Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of agilon health, inc. – AGL - GlobeNewswire Inc.
Agilon health reinstates $5.82B revenue guidance for 2025 while streamlining cost base - MSN
Using Bollinger Bands to evaluate agilon health inc.2025 Price Targets & Weekly Stock Breakout Alerts - newser.com
symbol__ Stock Quote Price and Forecast - CNN
A Quick Look at Today's Ratings for Agilon Health(AGL.US), With a Forecast Between $1 to $1 - 富途牛牛
Signal strength of agilon health inc. stock in tech scanners2025 Pullback Review & Free Verified High Yield Trade Plans - newser.com
What MACD trends signal for agilon health inc. stockTreasury Yields & Proven Capital Preservation Tips - newser.com
agilon health (AGL) Revenue Growth Outpaces Market but Losses Deepen, Testing Bull Narratives - Yahoo Finance
Agilon Health (AGL) Reports Q3 Loss, Tops Revenue Estimates - sharewise.com
agilon health inc. stock prediction for this weekQuarterly Earnings Report & Consistent Profit Focused Trading Strategies - newser.com
Vanguard Group Inc Reduces Stake in Agilon Health Inc - GuruFocus
Agilon Health (NYSE:AGL) Announces Earnings Results - MarketBeat
Agilon Health’s Earnings Call: Mixed Sentiments and Future Prospects - TipRanks
Why agilon health inc. stock remains stableWeekly Trade Review & Free High Accuracy Swing Entry Alerts - newser.com
AGL Investor News: If You Have Suffered Losses in agilon health, inc. (NYSE: AGL), You Are ... - Caledonian Record
Wells Fargo Maintains agilon health (AGL) Overweight Recommendation - Nasdaq
Agilon Health Q3 2025 Earnings: Revenue Beat Sparks Stock RallyNews and Statistics - IndexBox
agilon health (AGL) Shares Skyrocket, What You Need To Know - TradingView
AGL Q3 Deep Dive: Revenue Beats Expectations Amid Profitability Challenges and Strategic Realignment - Yahoo Finance
Will agilon health inc. stock outperform value stocksWeekly Profit Recap & Free Safe Entry Trade Signal Reports - newser.com
Will agilon health inc. stock maintain growth storyJuly 2025 Final Week & Pattern Based Trade Signal System - newser.com
Agilon: Q3 Earnings Snapshot - CT Insider
Applying Elliott Wave Theory to agilon health inc.Portfolio Value Summary & Accurate Intraday Trade Tips - newser.com
Chart based analysis of agilon health inc. trendsJuly 2025 Earnings & Weekly Top Gainers Trade List - newser.com
Agilon Health Reports Q3 2025 Earnings and Outlook - TipRanks
Transcript : Agilon health, inc., Q3 2025 Earnings Call, Nov 04, 2025 - MarketScreener
Here's What Key Metrics Tell Us About Agilon (AGL) Q3 Earnings - sharewise.com
Agilon Health Missed Expectations Despite Beating Revenue Forecasts - Finimize
Earnings call transcript: Agilon Health posts wider EPS loss in Q3 2025 - Investing.com Nigeria
Agilon Health Q3 2025 Earnings Report: Revenue Beat, Wider LossNews and Statistics - IndexBox
Agilon Health Inc Stock (AGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.72%
2.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):